Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
Delayed Quote. Delayed NASDAQ OMX COPENHAGEN - 10/23 10:59:47 am
445.25 DKK   +0.26%
10/16NOVO NORDISK : Buy rating from Goldman Sachs
MD
10/14NOVO NORDISK : Buy rating from JP Morgan
MD
10/12NOVO NORDISK : Credit Suisse gives a Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

NOVO NORDISK : Kepler Cheuvreux reaffirms its Neutral rating

share with twitter share with LinkedIn share with facebook
08/14/2020 | 06:54am EDT

Kepler Cheuvreux's research confirms his advice and maintains his neutral opinion on the stock. The target price is reviewed upwards from DKK 290 to DKK 392.

© MarketScreener with dpa-AFX Analyser 2020

share with twitter share with LinkedIn share with facebook
All news about NOVO NORDISK A/S
10/16NOVO NORDISK : Buy rating from Goldman Sachs
MD
10/14NOVO NORDISK : Buy rating from JP Morgan
MD
10/12NOVO NORDISK : Credit Suisse gives a Buy rating
MD
10/12NOVO NORDISK A/S : Bavarian Nordic Announces Appointment of Anu Helena Kerns as ..
AQ
10/12NOVO NORDISK A/S : Conference call regarding updated 2020 outlook 9 October 2020
PU
10/12NOVO NORDISK A/S : Alexander Mann Solutions partners with Novo Nordisk to suppor..
AQ
10/12NOVO NORDISK A/S : – Share repurchase programme
AQ
10/09EUROPE : European stocks rack up second week of gains, Pandora leaps
RE
10/09NOVO NORDISK : Credit Suisse gives a Buy rating
MD
10/09GLOBAL MARKETS LIVE : Acquisitions, acquisitions, acquisitions
More news
Financials
Sales 2020 128 B 20 361 M 20 361 M
Net income 2020 42 192 M 6 727 M 6 727 M
Net cash 2020 10 613 M 1 692 M 1 692 M
P/E ratio 2020 24,7x
Yield 2020 2,02%
Capitalization 1 035 B 165 B 165 B
EV / Sales 2020 8,02x
EV / Sales 2021 7,50x
Nbr of Employees 43 526
Free-Float 75,1%
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 447,63 DKK
Last Close Price 445,25 DKK
Spread / Highest target 22,4%
Spread / Average Target 0,53%
Spread / Lowest Target -31,5%
EPS Revisions
Managers
NameTitle
Lars Fruergaard Jørgensen President & Chief Executive Officer
Helge Lund Chairman
Maziar Mike Doustdar Executive Vice President-International Operations
Karsten Munk Knudsen Chief Financial Officer & Executive Vice President
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
NOVO NORDISK A/S15.16%164 690
JOHNSON & JOHNSON-0.43%382 391
ROCHE HOLDING AG-5.29%280 884
PFIZER INC.-2.55%212 162
MERCK & CO., INC.-12.23%201 909
NOVARTIS AG-16.78%185 999